High content analysis (HCA) of 3D spheroid models has the potential to provide valuable information to help researchers untangle disease pathophysiology and assess novel therapies more effectively.
However, the transition from 2D monolayer models to dense 3D spheroids in HCA applications is not trivial and requires 3D-optimized protocols, instrumentation, and resources.
In this webinar, InSphero Senior Application Scientist and SBI2 President Elect Judi Wardwell-Swanson and Yokogawa Life Sciences Senior Executive Dr. Gerd Heimlich will:
- Provide a detailed introduction to HCA with multicellular 3D models for drug discovery
- Review platform requirements and recommendations
- Present two case studies to illustrate the power of HCA in complex drug discovery applications